Stockhead
Optiscan progresses its breast cancer imaging study reaching the halfway mark on its path to FDA submissions. ... Read More The post Long Shortz with Optiscan Imaging: Breast cancer study reaches key milestone appeared first on Stockhead .
Go to News Site